Evidence map›Paper›PMID 40769975›Full record

ArticleNature communications2025

Antimicrobial peptide class that forms discrete β-barrel stable pores anchored by transmembrane helices.

Seth W Dickey, Dylan J Burgin, Ama N Antwi, Amer Villaruz, Madeline R Galac, Gordon Y C Cheung, Tatiana K Rostovtseva, Liam J Worrall, Aleksander C Lazarski, Elio A Cino and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. TMcin RiPP biosynthesis in the cellular membrane.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Seth W DickeyNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. sdickey@umd.edu.ORCID http://orcid.org/0000-0003-3200-2388
Dylan J BurginNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Ama N AntwiDepartment of Veterinary Medicine, University of Maryland, College Park, MD, USA.ORCID http://orcid.org/0000-0002-7419-1239
Amer VillaruzNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Madeline R GalacBioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Gordon Y C CheungNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-1796-6058
Tatiana K RostovtsevaEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-7299-7362
Liam J WorrallDepartment of Biochemistry and Molecular Biology and the Centre for Blood Research, University of British Columbia, Vancouver, BC, Canada.
Aleksander C LazarskiDepartment of Biochemistry and Molecular Biology and the Centre for Blood Research, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0003-1364-2371
Elio A CinoDepartment of Biological Sciences and Centre for Molecular Simulation, University of Calgary, Calgary, Canada.
D Peter TielemanDepartment of Biological Sciences and Centre for Molecular Simulation, University of Calgary, Calgary, Canada.ORCID http://orcid.org/0000-0001-5507-0688
Sergey M BezrukovEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Natalie C J StrynadkaDepartment of Biochemistry and Molecular Biology and the Centre for Blood Research, University of British Columbia, Vancouver, BC, Canada.
Michael OttoNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. motto@niaid.nih.gov.ORCID http://orcid.org/0000-0002-2222-4115

Funding

Biophysics of Large Membrane ChannelsZIAHD000072 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI BEZRUKOV, SERGEY M · 2009 to 2025
$22.8M
Staphylococcal pathogenesisZIAAI000904 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI OTTO, MICHAEL · 2009 to 2025
$22.6M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) HHSN316201300006W/75N93022F00001Intramural NIH HHS ZIA AI000904Intramural NIH HHS ZIA HD000072
6 · The paper itself

Abstract

Bacteriocin peptides are weapons of inter-bacterial warfare and belong to the larger group of antimicrobial peptides (AMPs), which are frequently proposed as alternatives to antibiotics. Many AMPs kill by destroying the target's cytoplasmic membrane using short-lived membrane perturbations. Contrastingly, protein toxins form large pores by stably assembling in the target membrane. Here we describe an AMP class termed TMcins (for transmembrane helix-containing bacteriocin), in which half of the AMP forms a transmembrane helix. This characteristic allows TMcin to assemble into stable and large oligomeric pores. The biosynthetic locus of TMcin, which was broadly active against Gram-positive bacteria, is distributed throughout two major bacterial phyla, yet bears no homology to previously reported bacteriocin biosynthetic gene clusters. Our discovery of an AMP class that achieves pore stability otherwise only found in protein toxins transforms our current understanding of AMP structure and function and underscores the continuing importance of phenotype-initiated investigations in uncovering wholly uncharacterized antimicrobials.

Indexed as

Antimicrobial PeptidesBacteriocinsAmino Acid SequenceAnti-Bacterial AgentsCell MembraneGram-Positive BacteriaProtein Structure, SecondaryAnti-Bacterial AgentsAntimicrobial PeptidesBacteriocins

Identifiers

PMID40769975
PMCPMC12328743

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.